Physician
Oncology
Dr. Wadih Arap, MD
|
|
Give Review
Wadih Arap works in the field of Oncology. He over the years received 1 awards: "Elected Member". Wadih Arap is also a published doctor. He has 100 publication published. The most recent publication is: Chemotherapy targeted to tumor vasculature. He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Trends in United States Prostate Cancer Incidence Rates by Age and Stage, 1995-2012.
- Integrated nanotechnology platform for tumor-targeted multimodal imaging and therapeutic cargo release.
- Self-targeting of TNF-releasing Cancer cells in preclinical models of primary and metastatic tumors.
- AAVP displaying octreotide for ligand-directed therapeutic transgene deLivery in neuroendocrine tumors of the pancreas.
- Receptor Tyrosine Kinase EphA5 Is a Functional Molecular Target in Human Lung Cancer.
- Selection and identification of ligand peptides targeting a model of castrate-resistant osteogenic prostate Cancer and their receptors.
- Synchronous down-modulation of miR-17 family members is an early causative event in the retinal angiogenic switch.
- Targeting interleukin-11 receptor in leukemia and lymphoma: A functional ligand-directed study and hematopathology analysis of patient-derived specimens.
- Ligand-directed targeting of lymphatic vessels uncovers mechanistic insights in Melanoma metastasis.
- Discovery and horizontal follow-up of an autoantibody signature in human prostate Cancer.
- Drug design strategies for the treatment of prostate Cancer.
- A multifunctional streptococcal collagen-mimetic protein coating prevents bacterial adhesion and promotes osteoid formation on titanium.
- Design, development, and validation of a high-throughput drug-screening assay for targeting of human leukemia.
- CD13-positive bone marrow-derived myeloid Cells promote angiogenesis, tumor growth, and metastasis.
- Targeting mammalian organelles with internalizing phage (iPhage) libraries.
- Tissue plasminogen activator regulates Purkinje neuron development and survival.
- Platinum-Based Chemotherapy for Variant Castrate-Resistant Prostate Cancer.
- A physical sciences network characterization of non-tumorigenic and metastatic Cells.
- Mechanism of action and initial evaluation of a membrane active all-D-enantiomer antimicrobial peptidomimetic.
- Semiparametric Bayesian Inference for Phage Display Data.
- Blockade of inhibitors of apoptosis (IAPs) in combination with tumor-targeted deLivery of tumor necrosis factor-? leads to synergistic antitumor activity.
- Response to comment on "a peptidomimetic targeting white fat causes weight loss and improved insulin resistance in obese monkeys".
- Ligand-directed profiling of organelles with internalizing phage libraries.
- An antimicrobial peptidomimetic induces mucorales Cell death through mitochondria-mediated apoptosis.
- Modulation of the immune response by Systemic targeting of antigens to lymph nodes.
- Biopanning and rapid analysis of selective interactive ligands.
- An anti-angiogenic state in mice and humans with retinal photoreceptor Cell degeneration.
- Molecular addresses in blood vessels as targets for therapy.
- Vascular targeting and antigen presentation.
- Incorporation of tumor-targeting peptides into recombinant adeno-associated virus capsids.
- Exploring vascular heterogeneity for gene therapy targeting.
- CD13/APN is activated by angiogenic signals and is essential for capillary tube formation.
- Superfibronectin, a multimeric form of fibronectin, increases HIV infection of primary CD4+ T lymphocytes.
- Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis.
- Expression of integrin transcripts in human Cancer cells.
- Immunoblotting of integrins.
- Integrin-binding peptides derived from phage display libraries.
- Anti-Cancer activity of targeted pro-apoptotic peptides.
- Tumor targeting with a selective gelatinase inhibitor.
- NG2 proteoglycan-binding peptides target tumor neovasculature.
- Identification of receptor ligands with phage display peptide libraries.
- Chemotherapy targeted to tumor vasculature.
- Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display.
- Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model.
- Functional analysis of wild-type and Malignant glioma derived CDKN2Abeta alleles: evidence for an RB-independent growth suppressive pathway.
- Cyclin-dependent kinase 6 (CDK6) amplification in human Gliomas identified using two-dimensional separation of genomic DNA.
- Point mutations can inactivate in vitro and in vivo activities of p16(INK4a)/CDKN2A in human glioma.
- Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor.
- Replacement of the p16/CDKN2 gene suppresses human glioma Cell growth.
- Loss of P16INK4 expression is frequent in high grade Gliomas.
- Tumor and serum beta-2-microglobulin expression in women with breast Cancer.
- The human vascular mapping project. Selection and utilization of molecules for tumor endothelial targeting.
- Is annexin 7 a tumor suppressor gene in prostate Cancer?
- Translation of vascular diversity into targeted therapeutics.
- Spare the rod and spoil the eye.
- A 45-kDa ErbB3 secreted by prostate Cancer cells promotes bone formation.
- Profiling the molecular diversity of blood vessels.
- Optical systems for in vivo molecular imaging of Cancer.
- Mapping tumor vascular diversity by screening phage display libraries.
- Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors.
- Alpha v beta 5 integrin-dependent programmed Cell death triggered by a peptide mimic of annexin V.
- An artificially designed pore-forming protein with anti-tumor effects.
- Aminopeptidase N inhibitors and SARS.
- Targeting urothelium: ex vivo assay standardization and selection of internalizing ligands.
- Revisiting ethical guidelines for research with terminal wean and Brain-dead participants.
- A preclinical model for predicting drug response in soft-tissue sarcoma with targeted AAVP molecular imaging.
- Combinatorial targeting of the macropinocytotic pathway in leukemia and lymphoma Cells.
- Meeting report: innovations in prostate Cancer research.
- Tumor-targeted gene deLivery using molecularly engineered hybrid polymers functionalized with a tumor-homing peptide.
- Molecular targets on blood vessels for Cancer therapies in clinical trials.
- A population of multipotent CD34-positive adipose stromal Cells share pericyte and mesenchymal surface markers, reside in a periendothelial location, and stabilize end...
- The original Pathologische Anatomie Leiden-Endothelium monoclonal antibody recognizes a vascular endothelial growth factor binding site within neuropilin-1.
- A previously unrecognized protein-protein interaction between TWEAK and CD163: potential biological implications.
- Treatment of hypoxia-induced retinopathy with targeted proapoptotic peptidomimetic in a mouse model of Disease.
- Design and construction of targeted AAVP vectors for mammalian Cell transduction.
- Molecular PET imaging of HSV1-tk reporter gene expression using [18F]FEAU.
- Impaired angiogenesis in aminopeptidase N-null mice.
- Techniques to decipher molecular diversity by phage display.
- Display technologies: application for the discovery of drug and gene deLivery agents.
- In vivo detection of gold-imidazole self-assembly complexes: NIR-SERS signal reporters.
- State of the art. Cellular and molecular mechanisms of alveolar destruction in emphysema: an evolutionary perspective.
- Novel function of alternatively activated macrophages: stabilin-1-mediated clearance of SPARC.
- A hybrid vector for ligand-directed tumor targeting and molecular imaging.
- Synchronous selection of homing peptides for multiple tissues by in vivo phage display.
- Vascular targeting: recent advances and therapeutic perspectives.
- Antiangiogenic therapy decreases integrin expression in normalized tumor blood vessels.
- Networks of gold nanoparticles and bacteriophage as biological sensors and Cell-targeting agents.
- Ligand-directed surface profiling of human Cancer cells with combinatorial peptide libraries.
- Phenotypic diversity of the Lung vasculature in experimental models of metastases.
- Ethics guidelines for research with the recently dead.
- Structural basis for the interaction of a vascular endothelial growth factor mimic peptide motif and its corresponding receptors.
- Development of a ligand-directed approach to study the pathogenesis of invasive aspergillosis.
- Angiogenesis with pericyte abnormalities in a transgenic model of prostate Carcinoma.
- SPARC regulates extraCellular matrix organization through its modulation of integrin-linked kinase activity.
- Cooperative effects of aminopeptidase N (CD13) expressed by nonmalignant and Cancer cells within the tumor microenvironment.
- A peptidomimetic targeting white fat causes weight loss and improved insulin resistance in obese monkeys.
- Vascular ligand-receptor mapping by direct combinatorial selection in Cancer patients.
- Genetic basis for in vivo daptomycin resistance in enterococci.
- Identification of novel immunoregulatory molecules in human thymic regulatory CD4+CD25+ T Cells by phage display.
Procedures Preformed
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- Thoracentesis
Conditions Treated
- Adrenal Gland Cancer
- Anemia
- Bladder Cancer
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- Elected Member
Education
-
Memorial Sloan-Kettering Cancer Center -
Universidad de Sao Paulo Faculty of Medicine
Hospital
-
University of Texas M.D. Anderson Cancer Center
Drug Facts
| NPI NUMBER | 1487743092 | |
| NPPES Provider LastName | ARAP | |
| NPPES Provider FirstName | WADIH | |
| NPPES Provider ZIPCode | 871310001 | |
| NPPES Provider State | NM | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 195.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1487743092 |
| Last Name Of The Provider | ARAP |
| First Name Of The Provider | WADIH |
| View All |
Similar Doctors
|
|
Dr. Robert Okpara, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marc S. Hoffmann, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hagop M. Kantarjian, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Ralph G. Zinner, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Tri T. Vu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeffrey L. Jorgensen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard E. Champlin, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Mario Cervantes-Vazquez, MD |
|
Dr. Anthony P. Conley, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sarvari V. Yellapragada, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sa A. Wang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Zehra Kapadia, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shi-Ming Tu, MD |
|
|
Dr. Linus Ho, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yee L. Tham, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John V. Heymach, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Antonio C. Buzaid, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. An N. Hoang, MD |
|
Dr. Philip A. Salem, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Theodore F. Tenczynski, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Brian M. Thomas |